11. Preclinical Testing of Antibodies: Safety Aspects

  1. Prof. Dr. H.-J. Rehm2,
  2. Dr. G. Reed3
  1. Ronald W. James

Published Online: 20 MAR 2008

DOI: 10.1002/9783527620869.ch11

Biotechnology: A: Recombinant Proteins, Monoclonal Antibodies, and Therapeutic Genes, Volume 5a, Second Edition

Biotechnology: A: Recombinant Proteins, Monoclonal Antibodies, and Therapeutic Genes, Volume 5a, Second Edition

How to Cite

James, R. W. (2008) Preclinical Testing of Antibodies: Safety Aspects, in Biotechnology: A: Recombinant Proteins, Monoclonal Antibodies, and Therapeutic Genes, Volume 5a, Second Edition (eds H.-J. Rehm and G. Reed), Wiley-VCH Verlag GmbH, Weinheim, Germany. doi: 10.1002/9783527620869.ch11

Editor Information

  1. 2

    Institut für Mikrobiologie, Universität Münster, Corrensstraße 3, D-48149 Münster, FRG

  2. 3

    1029 N. Jackson St., #501-A, Milwaukee, WI 53202-3226, USA

Author Information

  1. Huntingdon, UK

Publication History

  1. Published Online: 20 MAR 2008
  2. Published Print: 26 NOV 1998

ISBN Information

Print ISBN: 9783527283156

Online ISBN: 9783527620869

SEARCH

Keywords:

  • modulation;
  • theoretical;
  • synthesized;
  • toxicological;
  • therapeutic

Summary

The prelims comprise:

  • Introduction

  • Regulatory Testing Requirements

  • Timing of Studies in Relation to Clinical Trials

  • Tissue Specificity and Cross-Reactivity

  • Pharmaco-Toxicological Testing